Holista CollTech Limited (HCT) is pleased to announce that it has been granted its patent in Taiwan, a market which has shown significant interest in ovine collagen. The Taiwanese Patent describes and protects the core method underlying the production of Holista CollTech’s ovine collagen until 20 May 2023. The granting of the Taiwanese Patent for ovine collagen production confirms its uniqueness and secures Holista CollTech’s position in the Taiwanese market as the only supplier of ovine collagen. The combination of granted patents in multiple jurisdictions and being first to market with an ovine collagen, strengthens Holista CollTech’s position as the only commercial supplier of ovine collagen. Holista CollTech Limited is also prosecuting patents in other jurisdictions such as the US and Japan which present significant market opportunities for the company. Patents have already been granted in Australia, New Zealand, South Africa, China and Europe.
Holista CollTech Ltd (HCT) is a merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd focusing on natural ingredients for health supplements and lifestyle products. The company is the only producer of sheep (ovine) collagen using its patented extraction methods and is on track to develop a nano encapsulated ovine collagen. It leads in research on herbs and food ingredients from Malaysia’s rainforest – the oldest in the world. The company’s mission is to build a world class company, focus on providing consumers with scientifically enhanced, engineered and tested natural health supplements and consumer products.
Tags: HCT, Healthcare, Holista CollTech, Patent Granted
